| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |